EMA has recommended granting a conditional marketing authorisation in the European Union for Idefirix (imlifidase), the first treatment for adult... Array

Content Original Link:

https://www.ema.europa.eu/en/news/new-treatment-enable-kidney-transplant-highly-sensitised-patients